References
- Aracki-Trenkic A, Stojanov D, Trenkic M, Radovanovic Z, Ignjatovic J, Ristic S, et al. 2016. Atypical presentation of posterior reversible encephalopathy syndrome: clinical and radiological characteristics in eclamptic patients. Bosnian Journal of Basic Medical Sciences 16:180–186.
- Cipolla MJ, Kraig RP. 2011. Seizures in women with preeclampsia: mechanisms and management. Fetal and Maternal Medicine Review 22:91–108.
- Fisher N, Saraf S, Egbert N, Homel P, Stein EG, Minkoff H. 2016. Clinical correlates of posterior reversible encephalopathy syndrome in pregnancy. The Journal of Clinical Hypertension 18:522–527.
- Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. 1996. A reversible posterior leukoencephalopathy syndrome. The New England Journal of Medicine 334:494–500.
- Honson EV, Craven I, Blank SC. 2012. Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness. Peritoneal Dialysis International 32:590–594.
- Lagana AS, Giordano D, Loddo S, Zoccali G, Vitale SG, Santamaria A, et al. 2017. Decreased endothelial progenitor cells (EPCs) and increased natural killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis. Archives of Gynecology and Obstetrics 295:867–872.
- Nasr R, Golara M, Berger J. 2010. Posterior reversible encephalopathy syndrome in a woman with pre-eclampsia. Journal of Obstetrics and Gynaecology 30:730–732.
- Raman R, Devaramane R, Jagadish GM, Chowdaiah S. 2017. Various imaging manifestations of posterior reversible encephalopathy syndrome (PRES) on magnetic resonance imaging (MRI). Polish Journal of Radiology 82:64–70.
- Roth C, Ferbert A. 2011. The posterior reversible encephalopathy syndrome: what's certain, what's new? Practical Neurology 11:136–144.
- Zwahlen M, Gerber S, Bersinger NA. 2007. First trimester markers for pre-eclampsia: placental vs. non-placental protein serum levels. Gynecologic and Obstetric Investigation 63:15–21.